HISAMITSU PHARMACEUTICAL CO INCHISAMITSU PHARMACEUTICAL CO INCHISAMITSU PHARMACEUTICAL CO INC

HISAMITSU PHARMACEUTICAL CO INC

No trades
See on Supercharts
Market capitalization
‪1.90 B‬EUR
‪86.19 M‬EUR
‪874.28 M‬EUR
‪34.12 M‬
Beta (1Y)
0.27

About HISAMITSU PHARMACEUTICAL CO INC

Headquarters
Tosu
Founded
1847
ISIN
JP3784600003
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HPX is 24.00 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HISAMITSU PHARMACEUTICAL CO INC stocks are traded under the ticker HPX.
HISAMITSU PHARMACEUTICAL CO INC is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HISAMITSU PHARMACEUTICAL CO INC has a max estimate of 26.02 EUR and a min estimate of 26.02 EUR.
HPX earnings for the last quarter are 0.15 EUR whereas the estimation was 0.16 EUR which accounts for −7.84% surprise. Estimated earnings for the next quarter are 0.13 EUR. See more details about HISAMITSU PHARMACEUTICAL CO INC earnings.
HISAMITSU PHARMACEUTICAL CO INC revenue for the last quarter amounts to ‪215.56 M‬ EUR despite the estimated figure of ‪208.19 M‬ EUR. In the next quarter revenue is expected to reach ‪424.27 M‬ EUR.
Yes, you can track HISAMITSU PHARMACEUTICAL CO INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMACEUTICAL CO INC stock right from TradingView charts — choose your broker and connect to your account.
HPX reached its all-time high on Oct 13, 2023 with the price of 32.20 EUR, and its all-time low was 23.80 EUR and was reached on Mar 5, 2024.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMACEUTICAL CO INC EBITDA is ‪112.67 M‬ EUR, and current EBITDA margin is 12.94%. See more stats in HISAMITSU PHARMACEUTICAL CO INC financial statements.